02.10.2007 15:57:00
|
BioReference Laboratories, Inc. to Speak at the William Blair Small-Cap Growth Stock Conference
BioReference Laboratories, Inc. (NASDAQ-"BRLI”)
announced today that Marc D. Grodman M.D., President and Chief Executive
Officer, is scheduled to speak at the William Blair Small-Cap Growth
Stock Conference on Wednesday, October 3, 2007, at The Palace Hotel
located in New York, NY. The BioReference Laboratories presentation is
scheduled to begin at 8:40 a.m. Eastern Time.
Those wishing to listen to the live audio Web cast may access it on the
following site http://www.wsw.com/webcast/blair9/brli/
and on the Company’s corporate Web site, www.bioreference.com.
Please go to the site ten minutes before the presentation is ready to
begin. You will need to register as well as download and install any
necessary audio software. The Web cast will be archived, on both Web
sites, for 30 days following the call.
About BioReference Laboratories, Inc.
The Company is the largest independent regional clinical laboratory in
the Northeast and has major market positions in physician offices,
nursing homes and correctional institutions. The Company is a full
service clinical laboratory with specialty capability, especially in the
areas of genomics, oncology, correctional health, and complimentary
medicine. PSIMedica, a business unit of the Company, is a clinical
knowledge management (CKM) organization offering an array of information
solutions for reducing healthcare costs and improving quality
performance based on a flexible, scalable software analytical engine
that utilizes all available source information, including claims data,
enrollment data, prescription data and laboratory data. The Company
provides a comprehensive connectivity solution to physicians that
includes disease management, laboratory reporting and ordering, as well
as claims and eligibility processing through CareEvolve, its web-based
healthcare portal.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Bio-Reference Laboratories Inc Stock Settlementmehr Nachrichten
Keine Nachrichten verfügbar. |